Position in ABVX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$35,047
+$9,437 QoQ
Shares Held
263
+14.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#256
of 302 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $446,515 across 36 Biotechnology names. ABVX ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COYA |
Coya Therapeutics, Inc.
|
26,171 | $153,100 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
1,500 | $85,830 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
168 | $83,450 | |
| 4 | 1,201 | $37,747 | |||
| 5 | ABVX |
Abivax S.A.
This page
|
263 | $35,047 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33 | $20,576 | |
| 7 | PBYI |
Puma Biotechnology, Inc.
|
1,170 | $9,488 | |
| 8 | XNCR |
Xencor Inc
|
468 | $7,534 |
All Filings in ABVX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,047 | 263 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $25,610 | 230 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $12,136 | 90 | Shares | Sole | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||